ABRILADA
Live / Registered — Registered (as of 28 Nov 2023)
What this means for you
Registered since 28 Nov 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Nov 2029: the §8 declaration of use).
Record
- Serial number
- 88907943
- Registration number
- 7231118
- Mark type
- Design + words
- Filed
- 08 May 2020
- Published for opposition
- 15 Sept 2020
- Registered
- 28 Nov 2023
- Next maintenance filing
- §8 declaration of use, due by 28 Nov 2029 (grace period to 28 May 2030)
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders, arthritis
Owner
- Pfizer Inc., New York, NY
- Pfizer Inc., New York, NY
- Pfizer Inc., New York, NY
Prosecution history
- 29 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 26 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Oct 2023 — USE AMENDMENT FILED
- 18 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2023 — SOU EXTENSION 5 GRANTED
- 13 Apr 2023 — SOU EXTENSION 5 FILED
- 20 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL